First impressions from Alligator’s new CEO
In June 2021, Søren Bregenholt began his new role as CEO for Lund-based company Alligator Bioscience. The company is about to initiate a phase II trial with mitazalimab, and drug candidate ATOR-1017 is soon to follow. Other projects are also advancing, and BioStock had the opportunity to talk to Bregenholt about his first impressions and.